Powering the agentic future
of healthcare decisions.

Datavant helps life sciences organizations securely discover, evaluate, connect, and use the world’s health data.

Industry impact at an unmatched scale

Of the top 20 pharma

350+

Ecosystem partners

75%

Of the top 100 U.S. health systems connected

41B

Patient-level records processed

100+

Epidemiologists, biostatisticians, and privacy experts

240+

Peer-reviewed publications enabled

Supporting the full journey from data discovery to evidence generation

Making health data more connected, trusted, and usable

Clinical
Development

Datavant connects proprietary and real-world data to unlock clinical insights that improve trial performance and accelerate R&D.

Learn More

Commercial
Pharma

Datavant turns fragmented commercial data into connected patient intelligence by linking and harmonizing first- and third-party data. Reveal the full patient journey, improve targeting and treatment initiation, and build a reusable foundation for commercial analytics and AI.

Learn More

Real-World Data
Partners

Datavant connects you to the nation’s largest health data ecosystem, helping you find fit-for-purpose data from hundreds of organizations across its partner network.

Learn More

Find, connect, and analyze real-world data with confidence.

Explore real-world data

What people say about us

“Datavant’s tokenization and matching capabilities paired with the security and scale of AWS and the benefits of AWS Clean Rooms will enable healthcare and life sciences organizations to better understand the patient journey…”

Akram Chetibi

General Manager of AWS Clean Rooms, Amazon Web Services

“The realization of national data linkage to support collaborative analytics would not be possible without Datavant’s technology, and is foundational to the success of the N3C [National COVID Cohort Collaborative].”

Melissa Haendel

PhD Marsico Chair in Data Science and Chief Research Informatics Officer, University of Colorado Anschutz Medical Campus, Principal Investigator for N3C

“The highest probability of success with an RWE strategy in secondary immunodeficiency (SID) to date.”

Customer

Top 20 pharma

“We needed speed, rigor, and clarity—and delivered all three. Their team helped us go from concept to evidence in record time.”

Customer

Global pharmaceutical company